Kura Oncology, Inc. - KURA

SEC FilingsOur KURA Tweets

About Gravity Analytica

Recent News

  • 06.18.2025 - Kura Oncology EHA Virtual Investor Event
  • 06.18.2025 - Kura Oncology EHA Virtual Investor Event
  • 06.12.2025 - Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress
  • 06.12.2025 - Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress
  • 06.10.2025 - Goldman Sachs 46th Annual Global Healthcare Conference 2025
  • 06.10.2025 - Goldman Sachs 46th Annual Global Healthcare Conference 2025
  • 06.06.2025 - Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 06.06.2025 - Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 06.06.2025 - Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 06.04.2025 - Jefferies Global Healthcare Conference

Recent Filings

  • 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
  • 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
  • 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
  • 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
  • 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
  • 06.06.2025 - 8-K Current report
  • 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
  • 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
  • 06.06.2025 - S-8 Securities to be offered to employees in employee benefit plans
  • 06.06.2025 - EX-99.1 EX-99.1